JP2017512500A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017512500A5 JP2017512500A5 JP2017502922A JP2017502922A JP2017512500A5 JP 2017512500 A5 JP2017512500 A5 JP 2017512500A5 JP 2017502922 A JP2017502922 A JP 2017502922A JP 2017502922 A JP2017502922 A JP 2017502922A JP 2017512500 A5 JP2017512500 A5 JP 2017512500A5
- Authority
- JP
- Japan
- Prior art keywords
- lactobacillus
- clostridium
- bacteroides
- composition
- host
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000193464 Clostridium sp. Species 0.000 claims description 26
- 210000004027 cell Anatomy 0.000 claims description 22
- 239000006041 probiotic Substances 0.000 claims description 21
- 235000018291 probiotics Nutrition 0.000 claims description 21
- 101710163270 Nuclease Proteins 0.000 claims description 20
- 230000000529 probiotic effect Effects 0.000 claims description 19
- 241000606125 Bacteroides Species 0.000 claims description 16
- 241000588724 Escherichia coli Species 0.000 claims description 14
- 241000186604 Lactobacillus reuteri Species 0.000 claims description 13
- 230000003115 biocidal effect Effects 0.000 claims description 13
- 229940001882 lactobacillus reuteri Drugs 0.000 claims description 13
- 108020004707 nucleic acids Proteins 0.000 claims description 13
- 102000039446 nucleic acids Human genes 0.000 claims description 13
- 150000007523 nucleic acids Chemical class 0.000 claims description 13
- 108090000623 proteins and genes Proteins 0.000 claims description 12
- 241000193403 Clostridium Species 0.000 claims description 10
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 9
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 9
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 9
- 241000186605 Lactobacillus paracasei Species 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 241000186660 Lactobacillus Species 0.000 claims description 7
- 230000002068 genetic effect Effects 0.000 claims description 7
- 229940039696 lactobacillus Drugs 0.000 claims description 7
- 241001148536 Bacteroides sp. Species 0.000 claims description 6
- 108091033409 CRISPR Proteins 0.000 claims description 6
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 6
- 108091028113 Trans-activating crRNA Proteins 0.000 claims description 6
- 239000012636 effector Substances 0.000 claims description 6
- 241001468157 Lactobacillus johnsonii Species 0.000 claims description 5
- 208000015181 infectious disease Diseases 0.000 claims description 5
- 230000002265 prevention Effects 0.000 claims description 5
- 238000010354 CRISPR gene editing Methods 0.000 claims description 4
- 244000199866 Lactobacillus casei Species 0.000 claims description 4
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 4
- 241000186840 Lactobacillus fermentum Species 0.000 claims description 4
- 241000191940 Staphylococcus Species 0.000 claims description 4
- 102000008579 Transposases Human genes 0.000 claims description 4
- 108010020764 Transposases Proteins 0.000 claims description 4
- 108010017070 Zinc Finger Nucleases Proteins 0.000 claims description 4
- 230000005540 biological transmission Effects 0.000 claims description 4
- 201000010099 disease Diseases 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- 230000001939 inductive effect Effects 0.000 claims description 4
- 229940017800 lactobacillus casei Drugs 0.000 claims description 4
- 229940012969 lactobacillus fermentum Drugs 0.000 claims description 4
- 230000001717 pathogenic effect Effects 0.000 claims description 4
- 241000894007 species Species 0.000 claims description 4
- 239000003053 toxin Substances 0.000 claims description 4
- 231100000765 toxin Toxicity 0.000 claims description 4
- 108700012359 toxins Proteins 0.000 claims description 4
- 239000000304 virulence factor Substances 0.000 claims description 4
- 230000007923 virulence factor Effects 0.000 claims description 4
- 241000186394 Eubacterium Species 0.000 claims description 3
- 244000057717 Streptococcus lactis Species 0.000 claims description 3
- 235000014897 Streptococcus lactis Nutrition 0.000 claims description 3
- 238000005202 decontamination Methods 0.000 claims description 3
- 230000003588 decontaminative effect Effects 0.000 claims description 3
- 244000000015 environmental pathogen Species 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 210000003491 skin Anatomy 0.000 claims description 3
- 241000456624 Actinobacteria bacterium Species 0.000 claims description 2
- 241000544634 Actinomyces graevenitzii Species 0.000 claims description 2
- 241000186066 Actinomyces odontolyticus Species 0.000 claims description 2
- 241000702460 Akkermansia Species 0.000 claims description 2
- 241001580959 Alistipes finegoldii Species 0.000 claims description 2
- 241001135230 Alistipes putredinis Species 0.000 claims description 2
- 241001258698 Allisonella Species 0.000 claims description 2
- 241001464864 Anaerococcus vaginalis Species 0.000 claims description 2
- 241001580965 Anaerofustis stercorihominis Species 0.000 claims description 2
- 241000428313 Anaerotruncus colihominis Species 0.000 claims description 2
- 241000193749 Bacillus coagulans Species 0.000 claims description 2
- 241000217846 Bacteroides caccae Species 0.000 claims description 2
- 241000606124 Bacteroides fragilis Species 0.000 claims description 2
- 241001135228 Bacteroides ovatus Species 0.000 claims description 2
- 241000606219 Bacteroides uniformis Species 0.000 claims description 2
- 241000606215 Bacteroides vulgatus Species 0.000 claims description 2
- 241000605059 Bacteroidetes Species 0.000 claims description 2
- 241000186000 Bifidobacterium Species 0.000 claims description 2
- 241000186018 Bifidobacterium adolescentis Species 0.000 claims description 2
- 241000483634 Bifidobacterium animalis subsp. lactis BB-12 Species 0.000 claims description 2
- 241001608472 Bifidobacterium longum Species 0.000 claims description 2
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 claims description 2
- 241001495171 Bilophila Species 0.000 claims description 2
- 241000186146 Brevibacterium Species 0.000 claims description 2
- 241001262170 Collinsella aerofaciens Species 0.000 claims description 2
- 241000220677 Coprococcus catus Species 0.000 claims description 2
- 241001464949 Coprococcus eutactus Species 0.000 claims description 2
- 241000186216 Corynebacterium Species 0.000 claims description 2
- 241001337994 Cryptococcus <scale insect> Species 0.000 claims description 2
- 241000186427 Cutibacterium acnes Species 0.000 claims description 2
- 241001464974 Cutibacterium avidum Species 0.000 claims description 2
- 241000235035 Debaryomyces Species 0.000 claims description 2
- 241000604463 Desulfovibrio piger Species 0.000 claims description 2
- 241000016537 Dorea longicatena Species 0.000 claims description 2
- 241000312060 Escherichia coli HS Species 0.000 claims description 2
- 241001302654 Escherichia coli Nissle 1917 Species 0.000 claims description 2
- 241000680146 Escherichia coli SE11 Species 0.000 claims description 2
- 241000023505 Escherichia coli SE15 Species 0.000 claims description 2
- 241001531192 Eubacterium ventriosum Species 0.000 claims description 2
- 241001608234 Faecalibacterium Species 0.000 claims description 2
- 241000605909 Fusobacterium Species 0.000 claims description 2
- 241000951752 Fusobacterium sp. oral clone R002 Species 0.000 claims description 2
- 241000193814 Gemella haemolysans Species 0.000 claims description 2
- 108020005004 Guide RNA Proteins 0.000 claims description 2
- 241000606790 Haemophilus Species 0.000 claims description 2
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 2
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 2
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims description 2
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims description 2
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 claims description 2
- 241001406038 Lactobacillus johnsonii NCC 533 Species 0.000 claims description 2
- 241000194036 Lactococcus Species 0.000 claims description 2
- 241000555676 Malassezia Species 0.000 claims description 2
- 241000192041 Micrococcus Species 0.000 claims description 2
- 241001135232 Odoribacter splanchnicus Species 0.000 claims description 2
- 241000606210 Parabacteroides distasonis Species 0.000 claims description 2
- 241000204306 Parabacteroides merdae Species 0.000 claims description 2
- 241001464887 Parvimonas micra Species 0.000 claims description 2
- 241000951725 Peptostreptococcus sp. oral clone CK035 Species 0.000 claims description 2
- 241000186429 Propionibacterium Species 0.000 claims description 2
- 241000192142 Proteobacteria Species 0.000 claims description 2
- 241001528479 Pseudoflavonifractor capillosus Species 0.000 claims description 2
- 241000872831 Roseburia faecis Species 0.000 claims description 2
- 241000398180 Roseburia intestinalis Species 0.000 claims description 2
- 241000192031 Ruminococcus Species 0.000 claims description 2
- 241000123753 Ruminococcus bromii Species 0.000 claims description 2
- 241000123754 Ruminococcus callidus Species 0.000 claims description 2
- 241001147691 Staphylococcus saprophyticus Species 0.000 claims description 2
- 241000194017 Streptococcus Species 0.000 claims description 2
- 241001134658 Streptococcus mitis Species 0.000 claims description 2
- 241000193991 Streptococcus parasanguinis Species 0.000 claims description 2
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 2
- 241000187747 Streptomyces Species 0.000 claims description 2
- 241001261005 Verrucomicrobia Species 0.000 claims description 2
- 241000186569 [Clostridium] leptum Species 0.000 claims description 2
- 241001147801 [Clostridium] scindens Species 0.000 claims description 2
- 241000193450 [Clostridium] symbiosum Species 0.000 claims description 2
- 241001531273 [Eubacterium] eligens Species 0.000 claims description 2
- 241001531197 [Eubacterium] hallii Species 0.000 claims description 2
- 241001531189 [Eubacterium] siraeum Species 0.000 claims description 2
- 241001464867 [Ruminococcus] gnavus Species 0.000 claims description 2
- 229940054340 bacillus coagulans Drugs 0.000 claims description 2
- 230000001580 bacterial effect Effects 0.000 claims description 2
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 2
- 210000002615 epidermis Anatomy 0.000 claims description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 2
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 2
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims description 2
- PSBAIJVSCTZDDB-UHFFFAOYSA-N phenyl acetylsalicylate Chemical compound CC(=O)OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 PSBAIJVSCTZDDB-UHFFFAOYSA-N 0.000 claims description 2
- 239000013612 plasmid Substances 0.000 claims description 2
- 229940055019 propionibacterium acne Drugs 0.000 claims description 2
- 229940055009 propionibacterium avidum Drugs 0.000 claims description 2
- 229960002181 saccharomyces boulardii Drugs 0.000 claims description 2
- 125000006850 spacer group Chemical group 0.000 claims description 2
- 230000000699 topical effect Effects 0.000 claims description 2
- 230000002103 transcriptional effect Effects 0.000 claims description 2
- 241001515965 unidentified phage Species 0.000 claims description 2
- 210000001635 urinary tract Anatomy 0.000 claims description 2
- 210000005253 yeast cell Anatomy 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 22
- 241001134569 Flavonifractor plautii Species 0.000 claims 1
- 241001531188 [Eubacterium] rectale Species 0.000 claims 1
- 208000012931 Urologic disease Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 208000014001 urinary system disease Diseases 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461970024P | 2014-03-25 | 2014-03-25 | |
| US61/970,024 | 2014-03-25 | ||
| PCT/US2015/022508 WO2015148680A1 (en) | 2014-03-25 | 2015-03-25 | Methods and genetic systems for cell engineering |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020132873A Division JP2021000092A (ja) | 2014-03-25 | 2020-08-05 | 細胞工学のための方法および遺伝システム |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017512500A JP2017512500A (ja) | 2017-05-25 |
| JP2017512500A5 true JP2017512500A5 (cg-RX-API-DMAC10.html) | 2018-04-19 |
Family
ID=54196352
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017502922A Pending JP2017512500A (ja) | 2014-03-25 | 2015-03-25 | 細胞工学のための方法および遺伝システム |
| JP2020132873A Pending JP2021000092A (ja) | 2014-03-25 | 2020-08-05 | 細胞工学のための方法および遺伝システム |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020132873A Pending JP2021000092A (ja) | 2014-03-25 | 2020-08-05 | 細胞工学のための方法および遺伝システム |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20170173086A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3122870B1 (cg-RX-API-DMAC10.html) |
| JP (2) | JP2017512500A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2015236045B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2943775A1 (cg-RX-API-DMAC10.html) |
| DK (1) | DK3122870T3 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2015148680A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013066438A2 (en) | 2011-07-22 | 2013-05-10 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
| WO2014160059A1 (en) | 2013-03-13 | 2014-10-02 | Gen9, Inc. | Compositions and methods for synthesis of high fidelity oligonucleotides |
| US9163284B2 (en) | 2013-08-09 | 2015-10-20 | President And Fellows Of Harvard College | Methods for identifying a target site of a Cas9 nuclease |
| US9359599B2 (en) | 2013-08-22 | 2016-06-07 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
| US9526784B2 (en) | 2013-09-06 | 2016-12-27 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
| US9340799B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | MRNA-sensing switchable gRNAs |
| US9322037B2 (en) | 2013-09-06 | 2016-04-26 | President And Fellows Of Harvard College | Cas9-FokI fusion proteins and uses thereof |
| US10584358B2 (en) | 2013-10-30 | 2020-03-10 | North Carolina State University | Compositions and methods related to a type-II CRISPR-Cas system in Lactobacillus buchneri |
| CN111218447B (zh) | 2013-11-07 | 2024-10-11 | 爱迪塔斯医药有限公司 | 使用统治型gRNA的CRISPR相关方法和组合物 |
| US20150166984A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting alpha-antitrypsin point mutations |
| US10787654B2 (en) | 2014-01-24 | 2020-09-29 | North Carolina State University | Methods and compositions for sequence guiding Cas9 targeting |
| AU2015236045B2 (en) | 2014-03-25 | 2021-09-23 | Ginkgo Bioworks, Inc. | Methods and genetic systems for cell engineering |
| EP3129490A4 (en) | 2014-04-08 | 2017-10-04 | North Carolina State University | Methods and compositions for rna-directed repression of transcription using crispr-associated genes |
| AU2015298571B2 (en) | 2014-07-30 | 2020-09-03 | President And Fellows Of Harvard College | Cas9 proteins including ligand-dependent inteins |
| US10450584B2 (en) | 2014-08-28 | 2019-10-22 | North Carolina State University | Cas9 proteins and guiding features for DNA targeting and genome editing |
| WO2016177682A1 (en) | 2015-05-06 | 2016-11-10 | Snipr Technologies Limited | Altering microbial populations & modifying microbiota |
| WO2016196361A1 (en) | 2015-05-29 | 2016-12-08 | North Carolina State University | Methods for screening bacteria, archaea, algae, and yeast using crispr nucleic acids |
| AU2016280002B2 (en) | 2015-06-15 | 2022-04-14 | North Carolina State University | Methods and compositions for efficient delivery of nucleic acids and RNA-based antimicrobials |
| US11286480B2 (en) | 2015-09-28 | 2022-03-29 | North Carolina State University | Methods and compositions for sequence specific antimicrobials |
| WO2017070632A2 (en) | 2015-10-23 | 2017-04-27 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
| JP6821598B2 (ja) | 2015-12-07 | 2021-01-27 | ザイマージェン インコーポレイテッド | Ｃｏｒｙｎｅｂａｃｔｅｒｉｕｍ ｇｌｕｔａｍｉｃｕｍ由来のプロモーター |
| US9988624B2 (en) | 2015-12-07 | 2018-06-05 | Zymergen Inc. | Microbial strain improvement by a HTP genomic engineering platform |
| WO2017112620A1 (en) | 2015-12-22 | 2017-06-29 | North Carolina State University | Methods and compositions for delivery of crispr based antimicrobials |
| EP4159848A1 (en) * | 2015-12-29 | 2023-04-05 | Monsanto Technology LLC | Novel crispr-associated transposases and uses thereof |
| CN115919906A (zh) | 2016-03-04 | 2023-04-07 | 加利福尼亚大学董事会 | 微生物聚生体及其用途 |
| US11766461B2 (en) | 2016-04-20 | 2023-09-26 | The Board of Trustees of the Stanford Junior | Compositions and methods for nucleic acid expression and protein secretion in Bacteroides |
| GB201609811D0 (en) | 2016-06-05 | 2016-07-20 | Snipr Technologies Ltd | Methods, cells, systems, arrays, RNA and kits |
| EP3478833A4 (en) | 2016-06-30 | 2019-10-02 | Zymergen, Inc. | METHOD FOR PRODUCING A BACTERIAL HEMOGLOBIN LIBRARY AND ITS USE |
| US10544411B2 (en) | 2016-06-30 | 2020-01-28 | Zymergen Inc. | Methods for generating a glucose permease library and uses thereof |
| WO2018027078A1 (en) | 2016-08-03 | 2018-02-08 | President And Fellows Of Harard College | Adenosine nucleobase editors and uses thereof |
| AU2017308889B2 (en) | 2016-08-09 | 2023-11-09 | President And Fellows Of Harvard College | Programmable Cas9-recombinase fusion proteins and uses thereof |
| WO2018039438A1 (en) | 2016-08-24 | 2018-03-01 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
| KR20240007715A (ko) | 2016-10-14 | 2024-01-16 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 핵염기 에디터의 aav 전달 |
| WO2018071841A1 (en) * | 2016-10-14 | 2018-04-19 | The Forsyth Institute | Compositions and methods for evading bacterial defense mechanisms |
| US11566238B2 (en) | 2016-12-15 | 2023-01-31 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for modulating growth of a genetically modified gut bacterial cell |
| WO2018119359A1 (en) | 2016-12-23 | 2018-06-28 | President And Fellows Of Harvard College | Editing of ccr5 receptor gene to protect against hiv infection |
| US11224624B2 (en) * | 2017-02-14 | 2022-01-18 | California Institute Of Technology | Modulation of microbial synthesis of 4-etylphenol and 4-ethylphenyl sulfate in behavior and disease |
| WO2018165504A1 (en) | 2017-03-09 | 2018-09-13 | President And Fellows Of Harvard College | Suppression of pain by gene editing |
| KR20190123328A (ko) | 2017-03-09 | 2019-10-31 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 암 백신 |
| CN110914310A (zh) | 2017-03-10 | 2020-03-24 | 哈佛大学的校长及成员们 | 胞嘧啶至鸟嘌呤碱基编辑器 |
| IL306092A (en) | 2017-03-23 | 2023-11-01 | Harvard College | Nucleic base editors that include nucleic acid programmable DNA binding proteins |
| US11560566B2 (en) | 2017-05-12 | 2023-01-24 | President And Fellows Of Harvard College | Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation |
| EP3658573A1 (en) | 2017-07-28 | 2020-06-03 | President and Fellows of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (pace) |
| EP3676376B1 (en) | 2017-08-30 | 2025-01-15 | President and Fellows of Harvard College | High efficiency base editors comprising gam |
| CA3082251A1 (en) | 2017-10-16 | 2019-04-25 | The Broad Institute, Inc. | Uses of adenosine base editors |
| US12406749B2 (en) | 2017-12-15 | 2025-09-02 | The Broad Institute, Inc. | Systems and methods for predicting repair outcomes in genetic engineering |
| US10760075B2 (en) | 2018-04-30 | 2020-09-01 | Snipr Biome Aps | Treating and preventing microbial infections |
| AU2019253714A1 (en) | 2018-04-10 | 2020-11-26 | Siolta Therapeutics, Inc. | Microbial consortia |
| WO2019226953A1 (en) | 2018-05-23 | 2019-11-28 | The Broad Institute, Inc. | Base editors and uses thereof |
| EP3820495A4 (en) | 2018-07-09 | 2022-07-20 | The Broad Institute Inc. | RNA-PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES |
| WO2020072250A1 (en) | 2018-10-01 | 2020-04-09 | North Carolina State University | Recombinant type i crispr-cas system and uses thereof for genome modification and alteration of expression |
| US12264330B2 (en) | 2018-10-01 | 2025-04-01 | North Carolina State University | Recombinant type I CRISPR-Cas system and uses thereof for killing target cells |
| US12203123B2 (en) | 2018-10-01 | 2025-01-21 | North Carolina State University | Recombinant type I CRISPR-Cas system and uses thereof for screening for variant cells |
| US10711267B2 (en) | 2018-10-01 | 2020-07-14 | North Carolina State University | Recombinant type I CRISPR-Cas system |
| US11851663B2 (en) | 2018-10-14 | 2023-12-26 | Snipr Biome Aps | Single-vector type I vectors |
| WO2020092453A1 (en) | 2018-10-29 | 2020-05-07 | The Broad Institute, Inc. | Nucleobase editors comprising geocas9 and uses thereof |
| US20220056457A1 (en) * | 2018-12-11 | 2022-02-24 | The University Of Western Ontario | Cis conjugative plasmid system |
| CN109652570A (zh) * | 2019-01-16 | 2019-04-19 | 中国人民解放军总医院 | 微生物在鉴别和/或区分不同种族个体中的应用 |
| US12351837B2 (en) | 2019-01-23 | 2025-07-08 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| CA3128507A1 (en) | 2019-02-06 | 2020-08-13 | Fred Hutchinson Cancer Research Center | Minicircle producing bacteria engineered to differentially methylate nucleic acid molecules therein |
| WO2020181264A1 (en) | 2019-03-07 | 2020-09-10 | The Trustees Of Columbia University In The City Of New York | Rna-guided dna integration using tn7-like transposons |
| WO2020191241A1 (en) | 2019-03-19 | 2020-09-24 | The Broad Institute, Inc. | Methods and compositions for editing nucleotide sequences |
| WO2020214842A1 (en) | 2019-04-17 | 2020-10-22 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| GB201906668D0 (en) * | 2019-05-12 | 2019-06-26 | Folium Food Science Ltd | Antibacterial agents |
| AU2020357816A1 (en) * | 2019-09-30 | 2022-04-14 | Sigma-Aldrich Co. Llc | Modulation of microbiota compositions using targeted nucleases |
| JP7624449B2 (ja) | 2019-10-07 | 2025-01-30 | シオルタ・セラピューティクス，インコーポレイテッド | 治療用医薬組成物 |
| US12435330B2 (en) | 2019-10-10 | 2025-10-07 | The Broad Institute, Inc. | Methods and compositions for prime editing RNA |
| WO2021119594A1 (en) * | 2019-12-13 | 2021-06-17 | The Regents Of The University Of California | Reducing antibiotic resistance in bacteria using pro-active genetics |
| KR20220116512A (ko) * | 2019-12-17 | 2022-08-23 | 시그마-알드리치 컴퍼니., 엘엘씨 | 박테로이데스의 게놈편집 |
| CA3177481A1 (en) | 2020-05-08 | 2021-11-11 | David R. Liu | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
| CN112029699B (zh) * | 2020-11-04 | 2021-06-08 | 中国农业科学院北京畜牧兽医研究所 | 一种基于内源CRISPR-Cas系统的丁酸梭菌基因编辑系统及其应用 |
| US11851664B2 (en) | 2020-12-24 | 2023-12-26 | Oakbio, Inc. | Methods for producing biochemicals using enzyme genes derived from a strain of Brevundimonas, and compositions made thereby |
| GB202209518D0 (en) | 2022-06-29 | 2022-08-10 | Snipr Biome Aps | Treating & preventing E coli infections |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0487159A1 (en) * | 1990-11-23 | 1992-05-27 | Unilever N.V. | A food-grade vector suitable for transforming a food-grade host cell, use of said vector for transforming food-grade host cells, and use of said transformed cells in biotransformation processes |
| US7005561B2 (en) * | 2000-03-08 | 2006-02-28 | University Of Georgia Research Foundation, Inc. | Arabitol or ribitol as positive selectable markers |
| JP2005519872A (ja) * | 2001-11-12 | 2005-07-07 | ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー | サルモネラ・ワクチン |
| KR101311562B1 (ko) * | 2003-08-14 | 2013-09-26 | 디에스엠 아이피 어셋츠 비.브이. | 미생물을 이용한 ｌ-아스코르브산의 생산 |
| FI116068B (fi) | 2003-09-15 | 2005-09-15 | Fit Biotech Oyj Plc | Uusi selektiojärjestelmä, siinä käyttökelpoinen vektori, bakteerisolukantoja sekä menetelmä solujen valikoimiseksi |
| ES2473625T3 (es) * | 2007-10-26 | 2014-07-07 | Brenda E. Moore | Composición probi�tica y métodos para inducir y mantener la pérdida de peso |
| JP5783503B2 (ja) * | 2008-09-03 | 2015-09-24 | 国立研究開発法人農業・食品産業技術総合研究機構 | 外来遺伝子を導入しない、非遺伝子組換えの遺伝子欠損株とその作製および選抜方法 |
| CN102612565B (zh) * | 2009-08-11 | 2016-04-06 | 桑格摩生物科学股份有限公司 | 靶向修饰的纯合生物体 |
| WO2011101696A1 (en) * | 2010-02-18 | 2011-08-25 | Cellectis | Improved meganuclease recombination system |
| DK2630156T3 (en) | 2010-10-20 | 2018-12-17 | Dupont Nutrition Biosci Aps | CRISPR-CAS SEQUENCES OF LACTOCOCCUS |
| ES2728782T3 (es) * | 2012-05-25 | 2019-10-28 | Univ California | Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN |
| EP4074330A1 (en) * | 2013-09-05 | 2022-10-19 | Massachusetts Institute of Technology | Tuning microbial populations with programmable nucleases |
| AU2015236045B2 (en) | 2014-03-25 | 2021-09-23 | Ginkgo Bioworks, Inc. | Methods and genetic systems for cell engineering |
-
2015
- 2015-03-25 AU AU2015236045A patent/AU2015236045B2/en not_active Ceased
- 2015-03-25 US US15/127,498 patent/US20170173086A1/en not_active Abandoned
- 2015-03-25 WO PCT/US2015/022508 patent/WO2015148680A1/en not_active Ceased
- 2015-03-25 JP JP2017502922A patent/JP2017512500A/ja active Pending
- 2015-03-25 DK DK15768011.7T patent/DK3122870T3/da active
- 2015-03-25 EP EP15768011.7A patent/EP3122870B1/en not_active Revoked
- 2015-03-25 CA CA2943775A patent/CA2943775A1/en not_active Abandoned
-
2020
- 2020-08-05 JP JP2020132873A patent/JP2021000092A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021000092A (ja) | 細胞工学のための方法および遺伝システム | |
| AU2023248066B2 (en) | Use of microbial communities for human and animal health | |
| Mills et al. | Enhancing the stress responses of probiotics for a lifestyle from gut to product and back again | |
| Ahmed | Genetically modified probiotics in foods | |
| US11542466B2 (en) | Methods and compositions for delivery of CRISPR based antimicrobials | |
| Mach | Clinical usefulness of probiotics | |
| Culligan et al. | Probiotics and gastrointestinal disease: successes, problems and future prospects | |
| Sheehan et al. | Improving gastric transit, gastrointestinal persistence and therapeutic efficacy of the probiotic strain Bifidobacterium breve UCC2003 | |
| Corcoran et al. | Life under stress: the probiotic stress response and how it may be manipulated | |
| Toh et al. | Genomic adaptation of the Lactobacillus casei group | |
| EP3554522B1 (en) | Probiotics for use in the treatment of diverticulosis and diverticular disease | |
| EP4074330A1 (en) | Tuning microbial populations with programmable nucleases | |
| US20170333493A1 (en) | Probiotic bacteria for the prevention and treatment of salmonella | |
| Ventura et al. | Bifidobacteria of the human gut: our special friends | |
| Azizian et al. | Genetic diversity of Lactobacillus spp. isolates from oral cavity and their probiotic and antimicrobial properties | |
| Upadrasta et al. | Improving the stress tolerance of probiotic cultures: recent trends and future directions | |
| Averina et al. | Identification and characterization of WhiB-like family proteins of the Bifidobacterium genus | |
| Wagner et al. | Potential hazards of probiotic bacteria for immunodeficient patients | |
| Karjalainen et al. | Real-time PCR assays for strain-specific quantification of probiotic strains in human faecal samples | |
| Azcarate-Peril et al. | Genomics of lactic acid bacteria: the post-genomics challenge–from sequence to function | |
| Douglas et al. | Genomic Evolution of Lactic Acid Bacteria: From Single Gene Function to the Pan‐genome | |
| LI et al. | Directional Screening for Reuterin-Producing Lactobacillus reuteri and Its Biological Characteristics | |
| US20250236838A1 (en) | E. coli nissle strain with improved transformation efficiency | |
| Tessema | Lactic acid bacteria and culture media for the production of potential antivirulence peptides against Salmonella typhimurium | |
| Goldiş | Efficiency of Treatment Targeted on Gut Microbiota in Inflammatory Bowel Diseases: Current Strategies |